A detailed history of Raymond James Trust N.A. transactions in Johnson & Johnson stock. As of the latest transaction made, Raymond James Trust N.A. holds 226,343 shares of JNJ stock, worth $32.8 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
226,343
Previous 217,494 4.07%
Holding current value
$32.8 Million
Previous $31.8 Million 15.39%
% of portfolio
0.81%
Previous 0.75%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$145.48 - $167.38 $1.29 Million - $1.48 Million
8,849 Added 4.07%
226,343 $36.7 Million
Q2 2024

Jul 25, 2024

BUY
$144.38 - $157.78 $125,321 - $136,953
868 Added 0.4%
217,494 $31.8 Million
Q1 2024

Apr 24, 2024

SELL
$155.22 - $162.74 $420,180 - $440,537
-2,707 Reduced 1.23%
216,626 $34.3 Million
Q4 2023

Jan 10, 2024

BUY
$145.6 - $158.88 $873,017 - $952,644
5,996 Added 2.81%
219,333 $34.4 Million
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $772,364 - $865,246
4,959 Added 2.38%
213,337 $33.2 Million
Q2 2023

Aug 15, 2023

BUY
$154.35 - $166.11 $2.05 Million - $2.21 Million
13,292 Added 6.81%
208,378 $34.5 Million
Q1 2023

May 03, 2023

BUY
$151.05 - $180.26 $982,429 - $1.17 Million
6,504 Added 3.45%
195,086 $30.2 Million
Q4 2022

Feb 02, 2023

BUY
$160.2 - $179.79 $1.2 Million - $1.35 Million
7,501 Added 4.14%
188,582 $33.3 Million
Q3 2022

Oct 31, 2022

BUY
$161.33 - $179.52 $519,159 - $577,695
3,218 Added 1.81%
181,081 $29.6 Million
Q2 2022

Jul 14, 2022

BUY
$168.19 - $186.01 $96,709 - $106,955
575 Added 0.32%
177,863 $31.6 Million
Q1 2022

May 12, 2022

BUY
$158.14 - $179.59 $555,387 - $630,720
3,512 Added 2.02%
177,288 $31.4 Million
Q4 2021

Jan 31, 2022

BUY
$155.93 - $173.01 $355,676 - $394,635
2,281 Added 1.33%
173,776 $29.7 Million
Q3 2021

Oct 18, 2021

SELL
$161.5 - $179.47 $1.32 Million - $1.47 Million
-8,169 Reduced 4.55%
171,495 $27.7 Million
Q2 2021

Jul 20, 2021

BUY
$159.48 - $171.07 $488,008 - $523,474
3,060 Added 1.73%
179,664 $29.6 Million
Q1 2021

May 03, 2021

SELL
$153.07 - $170.48 $358,336 - $399,093
-2,341 Reduced 1.31%
176,604 $29 Million
Q4 2020

Jan 13, 2021

SELL
$137.11 - $157.38 $158,773 - $182,246
-1,158 Reduced 0.64%
178,945 $28.2 Million
Q3 2020

Oct 14, 2020

BUY
$140.38 - $153.83 $910,925 - $998,202
6,489 Added 3.74%
180,103 $26.8 Million
Q2 2020

Jul 16, 2020

BUY
$128.81 - $155.51 $176,212 - $212,737
1,368 Added 0.79%
173,614 $24.4 Million
Q1 2020

Apr 17, 2020

BUY
$111.14 - $153.99 $804,764 - $1.12 Million
7,241 Added 4.39%
172,246 $22.6 Million
Q4 2019

Jan 14, 2020

BUY
$127.5 - $146.44 $801,720 - $920,814
6,288 Added 3.96%
165,005 $24.1 Million
Q3 2019

Oct 24, 2019

SELL
$126.95 - $142.14 $400,527 - $448,451
-3,155 Reduced 1.95%
158,717 $20.5 Million
Q2 2019

Jul 15, 2019

BUY
$131.15 - $144.24 $729,325 - $802,118
5,561 Added 3.56%
161,872 $22.5 Million
Q1 2019

Apr 15, 2019

SELL
$125.72 - $139.79 $226,673 - $252,041
-1,803 Reduced 1.14%
156,311 $21.9 Million
Q4 2018

Jan 29, 2019

BUY
$122.84 - $147.84 $553,517 - $666,167
4,506 Added 2.93%
158,114 $20.4 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $18,601 - $21,860
153 Added 0.1%
153,608 $21.2 Million
Q3 2018

Oct 16, 2018

BUY
$121.58 - $142.88 $94,102 - $110,589
774 Added 0.51%
153,455 $21.2 Million
Q2 2018

Nov 26, 2018

BUY
$119.4 - $131.76 $11,940 - $13,176
100 Added 0.07%
152,681 $18.5 Million
Q2 2018

Jul 11, 2018

BUY
$119.4 - $131.76 $179,219 - $197,771
1,501 Added 0.99%
152,581 $18.5 Million
Q1 2018

Apr 05, 2018

BUY
$125.1 - $148.14 $145,116 - $171,842
1,160 Added 0.77%
151,080 $19.4 Million
Q4 2017

Feb 02, 2018

SELL
$131.22 - $143.62 $510,314 - $558,538
-3,889 Reduced 2.53%
149,920 $20.9 Million
Q3 2017

Oct 24, 2017

SELL
$129.47 - $135.38 $180,610 - $188,855
-1,395 Reduced 0.9%
153,809 $20 Million
Q2 2017

Aug 10, 2017

BUY
N/A
155,204
155,204 $20.5 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Raymond James Trust N.A. Portfolio

Follow Raymond James Trust N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.